GILEAD SCIENCES, INC. — Director's Dealing 2014

May 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-05-08

Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-08	Common Stock	M	5367	$21.575	Acquired	136061	Direct
2014-05-08	Common Stock	M	34633	$23.60	Acquired	170694	Direct
2014-05-08	Common Stock	S	40000	$80.00	Disposed	130694	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-08	Non-Qualified Stock Option (right to buy)	$21.575	M	5367	Disposed	2018-01-30	Common Stock (5367)	Direct
2014-05-08	Non-Qualified Stock Option (right to buy)	$23.60	M	34633	Disposed	2021-01-19	Common Stock (34633)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.